You are here > Volunteers > Current Trials


To get notified of upcoming trials via Facebook visit our Q-Pharm Facebook page and 'like us'!

HAVE YOU BEEN RECEIVING OUR TRIAL NOTIFICATION EMAILS? If you are registered on our volunteer database to receive trial notifications via email, please add the following email address to your safe senders list to ensure that you receive the notifications:

For further information on any of the trials listed below please contact Q-Pharm Recruitment on 1300 QPHARM (1300 774 276 voicemail) or email us at

Please note all trials are conducted at our clinic located in the Clive Berghofer Cancer Research Centre, Level 5, 300c Herston Road HERSTON QLD 4006.

General Advertisment for Participants
Study code Study overview Eligibility Criteria Required Visit schedule summary Approximate visit dates

Further Information
Volunteers required to participate in clinical trials of new drugs and vaccines. - Healthy Females and Males.
- Aged between 18 to 85 years.
- BMI between 18 and 32.


- Screening medical.
- In addition some trials may require a number of clinic visit for 1 – 2 hour periods and or in-house stays at Q-Pharm clinic from 12 hours or as long as 7 days. 
 -Trial dependent.

Please register via the 'Volunteer Registration' section under the 'Volunteers' tab.


Healthy Participants
Study code Study overview Eligibility Criteria Required Visit schedule summary Approximate visit dates
QP13C20 Cholera Vaccine.

- Males and Females

- 18 - 45 years of age inclusive

- Females must be on either contraception or practicing abstinence.

- if a smoker, must be able to cease smoking for confinement periods, approximately 4 hours 

- Able to attend 1 x 4 hour confinement

- 2 x Follow up visits (approx. 1 hour each)

- Available for a phone call on day 181

Recruiting Now.

Trial commences 16/07/2014 with further available days over a 3 week period.

QP13C02 New treatment for malaria

- Healthy and between the ages of 18 to 55 years.

- Males or Post Menopausal Women

- Practicing effective contraception.

- Currently on no medications

- Willing to cease smoking and limit alcohol consumption.

Able to attend a 3 night stay and 5 follow up visits. 

Cohort 8A now open for recruitment.

Commencing Tuesday 29th July, 2014

QP13C09 Research for Malaria
- Healthy Males or Females between the ages of 18 to 50 years.
- Must be Blood Type 'A'
- Practicing effective contraception.
- Currently on no medications.
- Willing to cease smoking and alcohol consumption for theduration of the trial.
Able to attend a 1 night stay and approx. 20 follow up visits.

Cohort 2 now closed.

A further Cohort will be running.

Dates still to be advised.



QP13C05 New treatment for Malaria.

- Males and Females

- Generally healthy.

- Aged 18-45 inclusive.

- Practicing effective contraception.

- Non Smokers.

- Must not have travelled to or lived (>2 weeks) in a malaria endemic country in the past 12 months.

- Must not have had malaria previously.

- Must not be taking any prescription medications or over-the-counter supplements for 2 weeks prior to commencement of the trial.


Please contact Q-Pharm for full information on eligibility criteria.



Able to attend a 2 night stay and a 12 hour confinement period.

-32 Outpatient visits approx.

-3 Follow Up Phone Calls

Cohort 3B now closed.


 A further cohort yet to be confirmed.


Patient Based Participants
Study code Study overview Eligibility Criteria Required Visit schedule summary Approximate visit dates


product for  


- Plaque Psoriasis

covering at least

10% of your body

 - Aged 18-75 inclusive


 -Screening medical

-Two 44 hour stays in 

the Q-Pharm clinic

- 10 outpatient visits


 Recruiting for this trial has now closed.






All studies at Q-Pharm are conducted under Australian and International guidelines for medical research under the approval of a Human Research Ethics Committee that complies with the strict guidelines as set by the National Health and Medical Research Council. Participation in a trial is dependent on fulfilment of trial specific criteria and overseas visitors require appropriate visas for trial participation.